Selective and Potent Molecular Glue Degraders for NIMA‐Related Kinase 7
Angewandte Chemie International Edition · 17.03.2025 · 64 (12)
DOI: 10.1002/anie.202500169 ↗Kurz gefasst
Fachartikel in der Zeitschrift Angewandte Chemie International Edition, online erschienen am 21.02.2025. Verfasst von Lu Chen und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiation and Medical Oncology, Medical Research Institute, Frontier Science Center of Immunology and Metabolism, Zhongnan Hospital of …. Hauptthemen laut MEDLINE: NIMA-Related Kinases, Protein Kinase Inhibitors. Die Arbeit wurde bisher 27-mal zitiert (Crossref) und nennt 33 Literaturangaben. Gefördert von: National Key R&D Program of China, Fundamental Research Funds for the Central Universities, China, Shanghai Pujiang Talent Program.
Abstract (Originalsprache)
Molecular glue degraders (MGDs) represent a promising strategy for targeted protein degradation within cells. While chemoproteomics has unveiled hundreds of potential MGD targets, very few proteins are degraded by highly selective and potent MGDs. Here, we developed a novel glutarimide analog with a tetrahydroimidazo[1,2‐ a ]pyrazine scaffold that exhibited strong NIMA‐related kinase 7 (NEK7) degradation potential. Further optimization led to the identification of LC‐04‐045 as a leading NEK7 MGD candidate, demonstrating potent activity with a half‐maximal degradation (DC 50 ) of 7 nM and a maximum degradation (D max ) of 90 % in MOLT‐4 cells. Notably, LC‐04‐045 displayed high selectivity for NEK7 across the proteome. Mechanistic studies indicated that the degradation was mediated by the ubiquitin‐proteasome system (UPS) and relied on the glycine 57 (G57)‐containing degron motif in NEK7. Additionally, two amino acids adjacent to the degron motif were found to be crucial for modulating the compound's selectivity and potency, underscoring the significance of neighbouring residues in MGD design. Moreover, LC‐04‐045 effectively inhibited secretion of the downstream cytokines, including IL‐1β and IL‐18, highlighting the potential therapeutic applications of NEK7 MGDs in treating inflammatory diseases.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Radiation and Medical Oncology, Medical Research Institute, Frontier Science Center of Immunology and Metabolism, Zhongnan Hospital of Wuhan University, School of Pharmaceutical Sciences, Wuhan University,…
- Lingang Laboratory, Shanghai, 200031, China.
- Department of Cardiovascular Surgery, The First Affiliated Hospital of Anhui Medical University, 218 Jixi Road, Hefei, 230022, China.
- SpecAlly Life Technology Co., Ltd., Wuhan, Hubei, 430075, China.
- Department of Radiation and Medical Oncology, Hubei Key Laboratory of Tumor Biological Behaviors, Hubei Cancer Clinical Study Center, Zhongnan Hospital of Wuhan University, Wuhan, 430071, China.
ORCID-Profile: Baishan Jiang
Förderung
- National Key R&D Program of China
- Fundamental Research Funds for the Central Universities, China
- Shanghai Pujiang Talent Program
- National Natural Science Foundation of China
- National Key Research and Development Program of China
Zitieren
APA
Chen, L., Huang, L., Wen, W., Zeng, P., Wu, Y., Han, Q., Chen, X., Guo, Z., Yu, H., Lu, W., & Jiang, B. (2025). Selective and Potent Molecular Glue Degraders for NIMA‐Related Kinase 7. Angewandte Chemie International Edition, 64(12). https://doi.org/10.1002/anie.202500169
Vancouver
Chen L, Huang L, Wen W, Zeng P, Wu Y, Han Q, et al. Selective and Potent Molecular Glue Degraders for NIMA‐Related Kinase 7. Angewandte Chemie International Edition. 2025;64(12). doi:10.1002/anie.202500169
BibTeX
@article{Chen2025,
author = {Chen, Lu and Huang, Lu and Wen, Wuqiang and Zeng, Pingping and Wu, Yuanyuan and Han, Qiangqiang and Chen, Xi and Guo, Zhixiang and Yu, Haijun and Lu, Wenchao and Jiang, Baishan},
title = {Selective and Potent Molecular Glue Degraders for NIMA‐Related Kinase 7},
journal = {Angewandte Chemie International Edition},
year = {2025},
volume = {64},
number = {12},
doi = {10.1002/anie.202500169}
}
EUVIMED